Browsing byAuthorWebster, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 49  next >
Issue DateTitleAuthor(s)
2021-04-26An electronic decision support‐based complex intervention to improve management of cardiovascular risk in primary health care: a cluster randomised trial (INTEGRATE)Webster, R; Usherwood, T; Joshi, R; Saini, B; Armour, C; Critchley, S; Di Tanna, GL; Galgey, S; Hespe, CM; Jan, S; Karia, A; Kaur, B; Krass, I; Laba, T; Li, Q; Lo, S; Peiris, DP; Reid, C; Rodgers, A; Shiel, L; Strathdee, J; Zamora, N; Patel, A
2011-01An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.PILL Collaborative Group; Rodgers, A; Patel, A; Berwanger, O; Bots, M; Grimm, R; Grobbee, DE; Jackson, R; Neal, B; Neaton, J; Poulter, N; Rafter, N; Raju, PK; Reddy, S; Thom, S; Vander Hoorn, S; Webster, R
2022-02-25Are We There Yet? Exploring the Use of Single-Pill Combination Therapy in the Management of Raised Blood Pressure in AustraliaNguyen, LH; Bruyn, E; Webster, R; Murphy, A; Perel, P; Schutte, AE
2022-06-01Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical TrialGnanenthiran, SR; Wang, N; DiTanna, GL; Salam, A; Webster, R; DeSilva, HA; Guggilla, R; Jan, S; Maulik, PK; Naik, N; Selak, V; Thom, S; Prabhakaran, D; Schutte, AE; Patel, A; Rodgers, A
2020-11Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial.Wang, N; Salam, A; Webster, R; de Silva, A; Guggilla, R; Stepien, S; Mysore, J; Billot, L; Jan, S; Maulik, PK; Naik, N; Selak, V; Thom, S; Prabhakaran, D; Patel, A; Rodgers, A; TRIUMPH Study Group
2018-01-01Atrial Fibrillation Screen, Management and Guideline Recommended Therapy (AF SMART II) in the rural primary care setting: An implementation study protocolOrchard, JJ; Neubeck, L; Freedman, B; Webster, R; Patel, A; Gallagher, R; Li, J; Hespe, CM; Ferguson, C; Zwar, N; Lowres, N
2020-09Atrial Fibrillation Screen, Management, and Guideline-Recommended Therapy in the Rural Primary Care Setting: A Cross-Sectional Study and Cost-Effectiveness Analysis of eHealth Tools to Support All Stages of Screening.Orchard, J; Li, J; Freedman, B; Webster, R; Salkeld, G; Hespe, C; Gallagher, R; Patel, A; Kamel, B; Neubeck, L; Lowres, N
2019-09Barriers and Facilitators to the Use of Cardiovascular Fixed-Dose Combination Medication (Polypills) in Andhra Pradesh, India: A Mixed-Methods Study.Salam, A; Praveen, D; Patel, A; Tewari, A; Webster, R
2015-11-09Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme.GACD Hypertension Research Programme, Writing Group; Peiris, D; Thompson, SR; Beratarrechea, A; Cárdenas, MK; Diez-Canseco, F; Goudge, J; Gyamfi, J; Kamano, JH; Irazola, V; Johnson, C; Kengne, AP; Keat, NK; Miranda, JJ; Mohan, S; Mukasa, B; Ng, E; Nieuwlaat, R; Ogedegbe, O; Ovbiagele, B; Plange-Rhule, J; Praveen, D; Salam, A; Thorogood, M; Thrift, AG; Vedanthan, R; Waddy, SP; Webster, J; Webster, R; Yeates, K; Yusoff, K; Hypertension Research Programme members
2014-01-01Centralised and portable 'network forensics' using smartphone-based diagnostics: Case study - The mapping of tap water pH across Sydney, AustraliaHossain, MA; Canning, J; Ast, S; Rutledge, PJ; Webster, R; Jamalipour, A
2021-09-13Challenges and opportunities in employing digital health to address self-management needs of people with NCDs in IndiaGudi, N; Yadav, UN; John, O; Webster, R
2021-05-05Community Group-Based Models of Medication Delivery: Applicability to Cardiovascular Diseases.Kwon, C; Webster, R; Santo, K; Atkins, E
2020Community pharmacist workflow: Space for Pharmacy-Based Interventions and Consultation TimE (SPICE) study protocolKaria, AM; Balane, C; Norman, R; Robinson, S; Lehnbom, E; Durakovic, I; Laba, T-L; Joshi, R; Webster, R
2018-12Considering pharmacy workflow in the context of Australian community pharmacy: A pilot time and motion study.Cavaye, D; Lehnbom, EC; Laba, T-L; El-Boustani, E; Joshi, R; Webster, R
2010-01ConvalescenceDavidson, PM; Webster, R; Kucia, AM; Quinn, T
2023-05CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation.Yan, J; Kothur, K; Mohammad, S; Chung, J; Patel, S; Jones, HF; Keating, BA; Han, VX; Webster, R; Ardern-Holmes, S; Antony, J; Menezes, MP; Tantsis, E; Gill, D; Gupta, S; Kandula, T; Sampaio, H; Farrar, MA; Troedson, C; Andrews, PI; Pillai, SC; Heng, B; Guillemin, GJ; Guller, A; Bandodkar, S; Dale, RC
2022-10Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids.Yan, J; Kothur, K; Innes, EA; Han, VX; Jones, HF; Patel, S; Tsang, E; Webster, R; Gupta, S; Troedson, C; Menezes, MP; Antony, J; Ardern-Holmes, S; Tantsis, E; Mohammad, S; Wienholt, L; Pires, AS; Heng, B; Guillemin, GJ; Guller, A; Gill, D; Bandodkar, S; Dale, RC
2010-01Discharge Planning and Secondary PreventionDavidson, PM; Webster, R; Kucia, AM; Quinn, T
2021-01-01Effects of Low-dose Triple Combination Therapy on Time at Target Blood Pressure – Results From the TRIUMPH Randomized Controlled TrialGnanenthiran, S; Wang, N; Salam, A; Webster, R; de Silva, A; Schutte, A; Patel, A; Rodgers, A
2019-05Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials.Salam, A; Atkins, ER; Hsu, B; Webster, R; Patel, A; Rodgers, A